Company: LIMN
Filing Date: 2025-06-02
Form Type: 10-Q
Source: 0001410578-25-001388
Chunk: 8

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-02
Form: 10-Q
Item: Part II, Item 6E
Chunk 8
---
Item 6. Exhibits.

The following exhibits are filed as part of, or incorporated by reference into, this report:

No.    Description of Exhibit31.1​Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.32.1*​Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.101.INS​XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document101.SCH​XBRL Taxonomy Extension Schema Document101.CAL​XBRL Taxonomy Extension Calculation Linkbase Document101.DEF​XBRL Taxonomy Extension Definition Linkbase Document101.LAB​XBRL Taxonomy Extension Labels Linkbase Document101.PRE​XBRL Taxonomy Extension Presentation Linkbase Document104​Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

​

*Furnished herewith

​

​